[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]
Subject: Future of the "DITA for Pharmaceutical Content" subcommittee
Don Day and I are pleased to see a growing interest in DITA across
the pharmaceutical industry. A number of pharmaceutical companies
have implemented DITA to evaluate the standard, and the Drug
Information Association (DIA) included a session titled
"Implementing Structured Authoring: Understanding the DITA Model and
Its Applicability for Content and Metadata Management" in their
annual meeting this year (see http://tinyurl.com/cxcnpbm). At one time it appeared that a DITA TC subcommittee would play an active role in supporting these efforts. However, the Pharmaceutical Content subcommittee has been inactive for over 18 months now. At OASIS request, we are closing
subcommittees that either are inactive or have completed their
work. As TC chairs, Don Day and I are considering closing the
Pharma subcommittee, but before we do so, we wanted to shout
out to SC members and the TC members at-large to see if there
are any individuals interested in stepping forward and leading
this subcommittee and its work effort. Let us know if you have time and ability
to provide leadership for this subcommittee. Otherwise, we'll
make a motion to close the subcommittee at a future TC
meeting. (The subcommittee always can be reactivated at a time
when there is leadership and a group of committed members.) Best, Kris Kristen James Eberlein Principal consultant, Eberlein
Consulting +1 919 682-2290; kriseberlein (skype) |
[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]